Medivir
Medivir is a Swedish biotech company. Medivir focuses its research focus on oncology and particularly on innovative pharmaceuticals that meet substantial unmet medical needs. The pharmaceutical development work is conducted both in-house and through partnerships, usually with global pharmaceutical companies. Medivir has a leading expertise in the design of protease inhibitors and in the science of nucleotides and nucleosides.Medivir is listed on the Nasdaq Stockholm Mid Cap List.
Wikipage redirect
Link from a Wikipage to another Wikipage
primaryTopic
Medivir
Medivir is a Swedish biotech company. Medivir focuses its research focus on oncology and particularly on innovative pharmaceuticals that meet substantial unmet medical needs. The pharmaceutical development work is conducted both in-house and through partnerships, usually with global pharmaceutical companies. Medivir has a leading expertise in the design of protease inhibitors and in the science of nucleotides and nucleosides.Medivir is listed on the Nasdaq Stockholm Mid Cap List.
has abstract
Medivir is a Swedish biotech c ...... d market the product in China.
@en
Medivir är ett svenskt biotekn ...... ioteknik- och läkemedelsbolag.
@sv
founding year
industry
location
number of employees
Link from a Wikipage to an external page
Wikipage page ID
52,440,500
page length (characters) of wiki page
Wikipage revision ID
1,002,189,271
Link from a Wikipage to another Wikipage
area served
Global
@en
homepage
industry
key people
Uli Hacksell
@en
Location
Huddinge, Sweden
@en
logo
@en
name
Medivir AB
@en
num employees
products
Oncological R&D
@en
revenue
wikiPageUsesTemplate
subject
comment
Medivir is a Swedish biotech c ...... Nasdaq Stockholm Mid Cap List.
@en
Medivir är ett svenskt biotekn ...... ioteknik- och läkemedelsbolag.
@sv
label
Medivir
@en
Medivir
@sv
wasDerivedFrom
homepage
isPrimaryTopicOf
name
Medivir AB
@en